Modulating Oncolytic Adenovirus Immunotherapy by Driving Two Axes of the Immune System by Expressing 4-1BBL and CD40L

Human Gene Therapy, Ahead of Print.

Source: Human Gene Therapy - January 6, 2022 Category: Genetics & Stem Cells Authors: Shao-Chia Lu Michael J. Hansen Jack R. Hemsath Brian J. Parrett Brady N. Zell Michael A. Barry Source Type: research